z-logo
open-access-imgOpen Access
Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques
Author(s) -
Joost H. C. M. Kreijtz,
Yasemin Suezer,
Gerrie de Mutsert,
Judith M. A. van den Brand,
Geert van Amerongen,
Barbara S. Schnierle,
Thijs Kuiken,
Ron A. M. Fouchier,
Johannes Löwer,
Albert D. M. E. Osterhaus,
Gerd Sutter,
Guus F. Rimmelzwaan
Publication year - 2008
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/595984
Subject(s) - virology , influenza a virus subtype h5n1 , biology , hemagglutinin (influenza) , virus , heterologous , h5n1 genetic structure , immunity , influenza a virus , vaccinia , microbiology and biotechnology , immune system , recombinant dna , gene , immunology , medicine , infectious disease (medical specialty) , genetics , disease , covid-19 , pathology
Highly pathogenic avian influenza viruses of the H5N1 subtype have been responsible for an increasing number of infections in humans since 2003. More than 60% of infected individuals die, and new infections are reported frequently. In light of the pandemic threat caused by these events, the rapid availability of safe and effective vaccines is desirable. Modified vaccinia virus Ankara (MVA) expressing the hemagglutinin (HA) gene of H5N1 viruses is a promising candidate vaccine that induced protective immunity against infection with homologous and heterologous H5N1 influenza virus in mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom